HOUSTON--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced the launch of its new grant program, QbAccess. Created to make ADHD testing and care more accessible to ...
HOUSTON--(BUSINESS WIRE)--In response to the recent arrests of Done founder Ruthia He and clinical leader David Brody for the company’s alleged stimulant prescription practices, Qbtech, the global ...
Qbtech, the global leader in objective ADHD testing, today announced its one millionth patient milestone, amassing one of the most extensive data sets of patients tested for ADHD. Adopted by more than ...
HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech, a leader in objective ADHD assessment technology, announced new study findings demonstrating a strong correlation between changes in QbCheck ...
The U.K. National Institute for Health and Care Excellence endorsed the Qb Test by Qbtech AB of Stockholm to aid in diagnosis of attention deficit/hyperactivity disorder in those aged 6 to 17.
BioWorld - Wednesday, October 23, 2024 See today's BioWorld MedTech Home » NICE sees need for more evidence for tests for ADHD Upgrade your daily dose of biopharma and medtech news Subscribe to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results